Literature DB >> 24122378

[Validation of the IBS-SSS].

C Betz, K Mannsdörfer, S C Bischoff.   

Abstract

Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterised by abdominal pain, associated with stool abnormalities and changes in stool consistency. Diagnosis of IBS is based on characteristic symptoms and exclusion of other gastrointestinal diseases. A number of questionnaires exist to assist diagnosis and assessment of severity of the disease. One of these is the irritable bowel syndrome - severity scoring system (IBS-SSS). The IBS-SSS was validated 1997 in its English version. In the present study, the IBS-SSS has been validated in German language. To do this, a cohort of 60 patients with IBS according to the Rome III criteria, was compared with a control group of healthy individuals (n = 38). We studied sensitivity and reproducibility of the score, as well as the sensitivity to detect changes of symptom severity. The results of the German validation largely reflect the results of the English validation. The German version of the IBS-SSS is also a valid, meaningful and reproducible questionnaire with a high sensitivity to assess changes in symptom severity, especially in IBS patients with moderate symptoms. It is unclear if the IBS-SSS is also a valid questionnaire in IBS patients with severe symptoms because this group of patients was not studied. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2013        PMID: 24122378     DOI: 10.1055/s-0033-1335260

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  12 in total

1.  Brain Functional Interaction of Acupuncture Effects in Diarrhea-Dominant Irritable Bowel Syndrome.

Authors:  Kai Ma; Yongkang Liu; Wei Shao; Jianhua Sun; Jing Li; Xiaokun Fang; Jing Li; Zhongqiu Wang; Daoqiang Zhang
Journal:  Front Neurosci       Date:  2020-12-15       Impact factor: 4.677

2.  Evaluation of Benefit and Tolerability of IQP-CL-101 (Xanthofen) in the Symptomatic Improvement of Irritable Bowel Syndrome: A Double-Blinded, Randomised, Placebo-Controlled Clinical Trial.

Authors:  Felix Alt; Pee-Win Chong; Emily Teng; Ralf Uebelhack
Journal:  Phytother Res       Date:  2017-05-16       Impact factor: 5.878

3.  The structure of resilience in irritable bowel syndrome and its improvement through hypnotherapy: Cross-sectional and prospective longitudinal data.

Authors:  Johannes Peter; Ulrich S Tran; Maria Michalski; Gabriele Moser
Journal:  PLoS One       Date:  2018-11-12       Impact factor: 3.240

4.  A Microbial Signature of Psychological Distress in Irritable Bowel Syndrome.

Authors:  Johannes Peter; Camille Fournier; Marija Durdevic; Lukas Knoblich; Bettina Keip; Clemens Dejaco; Michael Trauner; Gabriele Moser
Journal:  Psychosom Med       Date:  2018-10       Impact factor: 4.312

5.  High Rates of Non-Response Across Treatment Attempts in Chronic Irritable Bowel Syndrome: Results From a Follow-Up Study in Tertiary Care.

Authors:  Yuanjun Dong; David Baumeister; Sabrina Berens; Wolfgang Eich; Jonas Tesarz
Journal:  Front Psychiatry       Date:  2019-10-02       Impact factor: 4.157

6.  The Gastrointestinal Pain Pointer: A Valid and Innovative Method to Assess Gastrointestinal Symptoms.

Authors:  Wendy A Henderson; Bridgett Rahim-Williams; Kevin H Kim; LeeAnne B Sherwin; Sarah K Abey; Angela C Martino; Nicolaas H Fourie; Margaret M Heitkemper; Anthony P Zuccolotto
Journal:  Gastroenterol Nurs       Date:  2017 Sep/Oct       Impact factor: 0.978

7.  Long-term response to gluten-free diet as evidence for non-celiac wheat sensitivity in one third of patients with diarrhea-dominant and mixed-type irritable bowel syndrome.

Authors:  Christian Barmeyer; Michael Schumann; Tim Meyer; Christina Zielinski; Torsten Zuberbier; Britta Siegmund; Jörg-Dieter Schulzke; Severin Daum; Reiner Ullrich
Journal:  Int J Colorectal Dis       Date:  2016-09-30       Impact factor: 2.571

8.  Quantifying Liver Stagnation Spleen Deficiency Pattern for Diarrhea Predominate Irritable Bowel Syndromes Using Multidimensional Analysis Methods.

Authors:  Zhongyu Huang; Zhengkun Hou; Xianhua Liu; Fengbin Liu; Yuefeng Wu
Journal:  Evid Based Complement Alternat Med       Date:  2018-02-12       Impact factor: 2.629

9.  Is body mass index associated with symptom severity and health-related quality of life in irritable bowel syndrome? A cross-sectional study.

Authors:  Yuanjun Dong; Sabrina Berens; Wolfgang Eich; Rainer Schaefert; Jonas Tesarz
Journal:  BMJ Open       Date:  2018-10-17       Impact factor: 2.692

10.  Intestinal Microbiome in Irritable Bowel Syndrome before and after Gut-Directed Hypnotherapy.

Authors:  Johannes Peter; Camille Fournier; Bettina Keip; Nina Rittershaus; Nicola Stephanou-Rieser; Marija Durdevic; Clemens Dejaco; Maria Michalski; Gabriele Moser
Journal:  Int J Mol Sci       Date:  2018-11-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.